<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Primex Pharmaceuticals AG 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=26657></link><description><![CDATA[Primex Pharmaceuticals AG 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 05 May 2026 14:08:28 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2016/02/3554153577_20160224161734_3026245404.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Primex Pharmaceuticals: New Acquisition Brings an Innovative Oral Solution for Pediatric Anesthesiology to the Market]]></title><link>https://www.newswire.co.kr/newsRead.php?no=818608</link><description><![CDATA[ZUG, Switzerland & NIMES, France--(Business Wire/Korea Newswire)--Swiss pharmaceutical company Primex Pharmaceuticals AG and French pharmaceutical laboratory Advicenne SA announced today a deal where Primex will acquire global rights for an advanced oral pharmaceutical candidate for pediatric anesthesiology developed by Advicenne. The market potential is evaluated as hundreds of millions of euros.  This oral s...]]></description><pubDate>Wed, 24 Feb 2016 16:20:00 +0900</pubDate></item></channel></rss>